KAIVEXINⓇ– 300
Route of administration
Subcutaneous
Composition – Each Multidose cartridge contains:
-
Enoxaparin Sodium I.P…….. 300 mg/3mL
-
(Porcine derived)
-
Phenol I.P…………………………..0.25% w/v
-
(As Preservative)
-
Water For Injections I.P…………………. q.s.
Indications
-
The prophylaxis of thromboembolic disorders of venous origin, in particular those which may be associated with orthopaedic or general surgery.
-
The prophylaxis of venous thromboembolism in medical patients bedridden due to acute illnesses including cardiac insufficiency, respiratory failure, or severe infections.
-
The treatment of venous thromboembolic disease presenting with deep vein thrombosis, pulmonary embolism or both.
-
The treatment of unstable angina and non-Q-wave myocardial infarction administered concurrently with aspirin.
-
Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI). The pre-vention of thrombus formation in the extracorporeal circulation during haemodialysis.
-